Exelixis outlines December PDUFA timeline for ZANZA CRC filing while adding $750M buyback authorization
Exelixis Inc · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $50.28
-5.1% in 1d after detection
Post-detection moves
1h
—
1d
-5.1%
3d
+2.1%
7d
+2.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS